Q2 2024 Holdings
Filed 2024-08-14 | 63 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $187.5M | 1,021,078 | 11.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $105.1M | 10,595,089 | 6.4% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $92.3M | 4,423,616 | 5.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $63.8M | 4,721,054 | 3.9% |
| Immunome Inc(IMNM) | COM | 45257U108 | $59.2M | 4,889,554 | 3.6% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $53.5M | 4,569,802 | 3.2% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $51.0M | 929,506 | 3.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $50.1M | 5,562,096 | 3.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $48.3M | 15,269,217 | 2.9% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $47.1M | 1,579,275 | 2.9% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $45.4M | 5,453,083 | 2.7% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $44.3M | 5,211,037 | 2.7% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $43.2M | 13,169,057 | 2.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $40.5M | 4,799,973 | 2.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $39.9M | 1,703,061 | 2.4% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $38.3M | 2,014,296 | 2.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $37.9M | 1,614,473 | 2.3% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $37.7M | 1,087,576 | 2.3% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $36.9M | 1,013,663 | 2.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $34.5M | 3,209,591 | 2.1% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $33.5M | 595,570 | 2.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $31.5M | 6,427,462 | 1.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $30.1M | 390,253 | 1.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $26.7M | 759,516 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $26.6M | 718,723 | 1.6% |
| Absci Corporation(ABSI) | COM | 00091E109 | $25.4M | 8,253,316 | 1.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $25.2M | 552,506 | 1.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $24.3M | 4,036,451 | 1.5% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $22.5M | 1,073,435 | 1.4% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $21.7M | 5,615,489 | 1.3% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $21.1M | 3,072,478 | 1.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $19.0M | 720,177 | 1.1% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $17.7M | 39,843 | 1.1% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $14.4M | 16,380,327 | 0.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $14.0M | 1,745,656 | 0.8% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $13.9M | 1,881,501 | 0.8% |
| Stryker Corporation(SYK) | COM | 863667101 | $13.4M | 39,483 | 0.8% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $10.7M | 2,074,350 | 0.6% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $10.2M | 94,405 | 0.6% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $9.7M | 213,024 | 0.6% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $8.9M | 3,031,009 | 0.5% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $8.0M | 560,971 | 0.5% |
| AC Immune SA(ACIU) | SHS | H00263105 | $7.2M | 1,807,704 | 0.4% |
| Verve Therapeutics Inc | COM | 92539P101 | $7.1M | 1,463,406 | 0.4% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $6.4M | 1,942,555 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.1M | 111,867 | 0.4% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $5.0M | 2,164,126 | 0.3% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $4.0M | 1,034,583 | 0.2% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $3.8M | 452,270 | 0.2% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $3.8M | 2,108,219 | 0.2% |